APA (7th ed.) Citation

Au, H., Eiermann, W., Robert, N., Pienkowski, T., Crown, J., Martin, M., . . . Slamon, D. (2013). Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, her2-positive early breast cancer: Results from the BCIRG 006 study. AlphaMed Press.

Chicago Style (17th ed.) Citation

Au, H., et al. Health-related Quality of Life with Adjuvant Docetaxel- and Trastuzumab-based Regimens in Patients with Node-positive and High-risk Node-negative, Her2-positive Early Breast Cancer: Results from the BCIRG 006 Study. AlphaMed Press, 2013.

MLA (9th ed.) Citation

Au, H., et al. Health-related Quality of Life with Adjuvant Docetaxel- and Trastuzumab-based Regimens in Patients with Node-positive and High-risk Node-negative, Her2-positive Early Breast Cancer: Results from the BCIRG 006 Study. AlphaMed Press, 2013.